argenx SE ARGX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 02/03/23 EST
370.95UNCH (UNCH)
Volume
506
Close
370.95quote price arrow down-1.32 (-0.35%)
Volume
205,874
52 week range
256.44 - 407.93
Loading...
  • Open370.00
  • Day High373.83
  • Day Low370.00
  • Prev Close372.27
  • 52 Week High407.93
  • 52 Week High Date12/01/22
  • 52 Week Low256.44
  • 52 Week Low Date03/08/22

Key Stats

  • Market Cap20.576B
  • Shares Out55.47M
  • 10 Day Average Volume0.20M
  • Dividend-
  • Dividend Yield-
  • Beta0.73
  • YTD % Change-2.08

KEY STATS

  • Open370.00
  • Day High373.83
  • Day Low370.00
  • Prev Close372.27
  • 52 Week High407.93
  • 52 Week High Date12/01/22
  • 52 Week Low256.44
  • 52 Week Low Date03/08/22
  • Market Cap20.576B
  • Shares Out55.47M
  • 10 Day Average Volume0.20M
  • Dividend-
  • Dividend Yield-
  • Beta0.73
  • YTD % Change-2.08

RATIOS/PROFITABILITY

  • EPS (TTM)-17.56
  • P/E (TTM)-21.13
  • Fwd P/E (NTM)-33.26
  • EBITDA (TTM)-825.668M
  • ROE (TTM)-30.64%
  • Revenue (TTM)262.609M
  • Gross Margin (TTM)83.75%
  • Net Margin (TTM)-346.06%
  • Debt To Equity (MRQ)0.33%

EVENTS

  • Earnings Date03/01/2023(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On argenx SE

 

Profile

MORE
argenx SE, formerly arGEN X BV, is the Netherlands-based biopharmaceutical company. It creates and develops a pipeline of differentiated antibody therapeutics using its discovery platform, Simple Antibody, which exploits characteristics of the llama immune system. The Company develops a pipeline of antibody therapeutics focused on cancer and autoimmune indications. It includes: ARGX-110, an antibody for heme malignancies and solid tumors, which modulates functions of tumor...
Peter Verhaeghe
Non-Executive Independent Chairman of the Board
Tim Van Hauwermeiren
Chief Executive Officer, Co-Founder, Executive Director
Keith Woods
Chief Operating Officer
Karl Gubitz
Chief Financial Officer
Malini Moorthy
General Counsel
Address
Willemstraat 5
Breda
4811 AH
Netherlands